The second largest generic pharmaceutical company in the U.S. by sales volume, Mylan continues to capitalize on its presence in that market, which is the world's largest.
Mylan's strong position in the U.S. results from its consistent ability to obtain the regulatory approvals needed to introduce new products, which is key to growth in the generics business. In addition, Mylan enjoys a long-standing reputation for quality and a time-tested ability to reliably deliver large volumes to customers.
The U.S. market continues to grow as an aging population, a strong desire to reduce health care outlays, and an increasing reliance on generics continue to fuel demand. Mylan North America is armed and ready to continue to meet U.S. market demands for high quality affordable generic medications.
Mylan's North American businesses include Mylan Pharmaceuticals, which is based in Morgantown, W.Va. Mylan's business in Canada, Mylan Technologies and UDL Laboratories.